Country

Philippines

Delft Light is being used in Philippines - in the urban area

Tuberculosis remains a major public health challenge in the Philippines, which carries one of the highest TB burdens globally. Drug-resistant TB continues to complicate treatment efforts, while gaps in diagnosis and access to care highlight the need for strengthened and reliable screening nationwide.

739K+ people

developed TB in 2023

37K+ TB-related deaths

were recorded

29K+ people 

with drug-resistant TB

163K+ people

went undiagnosed

Our work in Philippines

In response to the country’s urgent TB burden, we partnered with FIND and the International Organization for Migration (IOM) to introduce CAD4TB as an AI-supported screening solution. Through continued collaboration with national and international partners, we expanded deployment across multiple sites, strengthening access to early TB detection nationwide.

CAD4TB in Philippines

2018

We partnered with FIND and IOM to deploy the nation’s first CAD4TB, utilizing AI to aid in detecting TB-related abnormalities in chest X-rays.

Delft Light in Philippines

2021

This commitment expanded when they deployed 8 CAD4TB to support eight additional sites as part of the iNTP project, funded by USAID and supported by the Stop TB Partnership.

2021

We provided an additional CAD4TB to Medecins Sans Frontieres (MSF).

Making a difference in Paraguay

CAD4TB platform
Case Study

Philippines – Active TB Case-finding among High-risk Groups

Read article
CAD4TB in Philippines
Case Study

Philippines – Active TB Case-finding with CAD4TB

Read article

Connect with our representative in your country.

We work alongside Ministries of Health, implementing partners, and healthcare providers to ensure solutions are aligned with national strategies and local healthcare systems.

Mike Rosenmöller

Discover the in’s and out’s of our solutions in a private demo

During this conversation, you can
  • Review which solutions align with your programmatic and operational needs
  • Explore partnership opportunities and long-term collaboration
  • Address technical, clinical, and infrastructure considerations specific to your setting